Generic Name and Formulations:
Calcitonin-salmon (rDNA origin) 200 IU/spray; nasal spray.
Various generic manufacturers
Indications for Calcitonin-salmon:
Limitations Of use:
Not shown to increase BMD in early postmenopausal women.
1 spray (200Units) in alternating nostrils daily.
Correct hypocalcemia and other disorders (eg, Vit. D deficiency) prior to initiating; monitor serum calcium during therapy. Supplement diet with calcium (1g/day) and Vit. D (400 IU/day); reevaluate periodically. Seizures. Do periodic nasal exams; discontinue if severe nasal ulceration occurs. Increased risk of malignancies. Pregnancy (Cat.C), nursing mothers: not recommended.
May antagonize lithium; adjust dose.
Rhinitis, epistaxis, other nasal symptoms, back pain, arthralgia, headache; hypersensitivity reactions, antibody formation.
Formerly known under the brand name Fortical or Miacalcin.
Sign Up for Free e-newsletters
- Study Finds Association Between Folate Intake and Risk of Cutaneous Melanoma
- Qualitative Analysis of Myeloma Patients' Experience Following Hematopoietic Stem Cell Transplant
- Melanoma Outcomes Improved With Nivolumab Alone or Plus Ipilimumab
- Involved-Field Radiotherapy Plus Chemotherapy Prolonged PFS in Follicular Lymphoma
- Patient Fears of Placebo Use in Clinical Trials
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
- Genetic Link Between Depression and Breast Cancer Remains Unclear
- Bariatric Surgery Reduced Risk of Some Cancers in Obese Patients
- Bleeding Disorder Treatments: Hemophilia A
- Guideline Recommendations Offer No OS Benefit for Younger Patients With Rectal Cancer
- Bleeding Disorder Treatments: von Willebrand Disease
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|